News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,895 Results
Type
Article (41432)
Company Profile (251)
Press Release (659212)
Section
Business (205006)
Career Advice (2011)
Deals (35556)
Drug Delivery (98)
Drug Development (82022)
Employer Resources (172)
FDA (16236)
Job Trends (14901)
News (347194)
Policy (32910)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2583)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (49754)
ALS (81)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (107)
Approvals (16235)
Artificial intelligence (227)
Autoimmune disease (13)
Automation (14)
Bankruptcy (362)
Best Places to Work (11674)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (176)
Bladder cancer (57)
Brain cancer (24)
Breast cancer (245)
Cancer (1976)
Cardiovascular disease (153)
Career advice (1677)
Career pathing (29)
CAR-T (139)
Cell therapy (393)
Cervical cancer (17)
Clinical research (66286)
Collaboration (763)
Compensation (446)
Complete response letters (19)
COVID-19 (2785)
CRISPR (34)
C-suite (204)
Cystic fibrosis (98)
Data (1920)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (247)
Diagnostics (6341)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (110)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86288)
Editorial (34)
Employer branding (21)
Employer resources (146)
Events (112052)
Executive appointments (629)
FDA (17332)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (685)
Gene editing (94)
Generative AI (19)
Gene therapy (274)
GLP-1 (687)
Government (4510)
Grass and pollen (4)
Guidances (48)
Healthcare (18901)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (104)
Indications (26)
Infectious disease (2924)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (83)
Interviews (311)
IPO (16521)
IRA (41)
Job creations (3651)
Job search strategy (1426)
Kidney cancer (9)
Labor market (34)
Layoffs (453)
Leadership (15)
Legal (7963)
Liver cancer (70)
Lung cancer (289)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (269)
MASH (60)
Medical device (13317)
Medtech (13322)
Mergers & acquisitions (19501)
Metabolic disorders (636)
Multiple sclerosis (68)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1811)
NextGen: Class of 2025 (6529)
Non-profit (4500)
Northern California (2396)
Now hiring (37)
Obesity (344)
Opinion (204)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (20)
Patents (201)
Patient recruitment (93)
Peanut (46)
People (57326)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20727)
Phase II (29147)
Phase III (21713)
Pipeline (979)
Podcasts (53)
Policy (110)
Postmarket research (2617)
Preclinical (8775)
Press Release (66)
Prostate cancer (92)
Psychedelics (33)
Radiopharmaceuticals (245)
Rare diseases (354)
Real estate (5955)
Recruiting (65)
Regulatory (22369)
Reports (46)
Research institute (2353)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (3)
RSV (45)
Schizophrenia (62)
Series A (121)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2068)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3594)
State (2)
Stomach cancer (12)
Supply chain (62)
The Weekly (34)
United States (20939)
Vaccines (767)
Venture capitalists (37)
Webinars (12)
Weight loss (230)
Women's health (33)
Worklife (15)
Date
Today (82)
Last 7 days (605)
Last 30 days (2494)
Last 365 days (33669)
2025 (7739)
2024 (35335)
2023 (40220)
2022 (51368)
2021 (56042)
2020 (54408)
2019 (46659)
2018 (35136)
2017 (32279)
2016 (31696)
2015 (37734)
2014 (31531)
2013 (26569)
2012 (28795)
2011 (29527)
2010 (27721)
Location
Africa (768)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (38219)
Australia (6265)
California (5459)
Canada (1860)
China (468)
Colorado (244)
Connecticut (256)
Delaware (124)
Europe (82184)
Florida (809)
Georgia (190)
Idaho (57)
Illinois (489)
India (23)
Indiana (289)
Iowa (9)
Japan (141)
Kansas (101)
Kentucky (24)
Louisiana (7)
Maine (60)
Maryland (842)
Massachusetts (4104)
Michigan (208)
Minnesota (367)
Mississippi (2)
Missouri (75)
Montana (30)
Nebraska (26)
Nevada (56)
New Hampshire (62)
New Jersey (1554)
New Mexico (28)
New York (1566)
North Carolina (913)
North Dakota (8)
Northern California (2396)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1244)
Puerto Rico (9)
Rhode Island (26)
South America (1113)
South Carolina (18)
South Dakota (1)
Southern California (2068)
Tennessee (92)
Texas (813)
Utah (163)
Virginia (128)
Washington D.C. (58)
Washington State (509)
West Virginia (3)
Wisconsin (49)
700,895 Results for "meissa vaccines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine Designed to Protect Infants and Toddlers
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced positive safety and immunogenicity data for MV-012-968, Meissa’s intranasal live attenuated RSV vaccine candidate, from a clinical study in RSV-naïve (seronegative) participants between the ages of six and 36 months.
August 8, 2023
·
4 min read
Vaccines
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.
March 5, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Meissa Vaccines Announces Positive Interim Clinical Data for Its Intranasal Live Attenuated Respiratory Syncytial Virus (RSV) Vaccine Candidate for Infants
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced interim clinical data of MV-012-968, Meissa’s intranasal live attenuated RSV vaccine candidate, from a Phase 1c study in RSV-naïve (seronegative) infants and young children.
November 7, 2022
·
5 min read
Biotech Bay
Meissa Vaccines Presented at The White House Summit on the Future of COVID-19 Vaccines
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced that Martin Moore, Ph.D., cofounder and Chief Scientific Officer of Meissa, spoke on a panel entitled, “Innovation in Vaccine Delivery,” at the Summit on the Future of COVID-19 Vaccines hosted by The White House Office for COVID-19 Response.
July 27, 2022
·
4 min read
Vaccines
Doctors Rally Behind Vaccines as Doubts, Misinformation Mount
A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.
March 20, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Business
Meissa Vaccines Appoints Frank Glavin Chief Executive Officer
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced the appointment of Frank Glavin as Chief Executive Officer, bringing more than 20 years of biotech and pharma experience across the biotech value chain from early-stage research through to commercial planning and business development.
July 11, 2022
·
5 min read
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Merck Unveils New Facility to Increase Vaccine Production Capacity
March 11, 2025
·
4 min read
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first death from measles since 2015.
February 27, 2025
·
2 min read
·
Tristan Manalac
1 of 70,090
Next